| Literature DB >> 32505499 |
Gaetano Alfano1, Annachiara Ferrari2, Francesco Fontana3, Francesca Damiano3, Andrea Solazzo2, Giacomo Mori3, Gianni Cappelli4.
Abstract
T-cell large granular lymphocytic (T-LGL) leukemia is a rare clonal proliferation presenting with cytopenia, splenomegaly, and autoimmune manifestations. It has rarely been described in recipients of solid organ transplants. We report the clinical case of a young kidney transplant recipient that developed T-LGL leukemia 3 years after kidney transplantation. The disorder manifested with a severe form of autoimmune hemolytic anemia in the absence of other laboratory abnormalities. The anemia was successfully treated with an intense course of corticosteroids ands witch of immunosuppressive therapy from a calcineurin inhibitor to sirolimus, a mammalian target of rapamycin inhibitor. Our case shows that autoimmune hemolytic anemia can be a life-threatening manifestation of T-LGL disease. The antiproliferative effects of sirolimus may be useful in the treatment of symptoms of T-LGL leukemia in kidney transplantation.Entities:
Year: 2020 PMID: 32505499 DOI: 10.1016/j.transproceed.2020.02.183
Source DB: PubMed Journal: Transplant Proc ISSN: 0041-1345 Impact factor: 1.066